These findings appear on-line in the Journal of Thoracic and Cardiovascular Surgery currently.

‘Our study found intense treatment of node-negative invasive T3 and T4 NSCLC with induction chemoradiotherapy may significantly improve survival,’ said business lead writer Benedict Daly, MD, chair of the department of cardiothoracic medical procedures at BUSM.. Aggressive treatment of T4 and T3 NSCLC with induction chemoradiotherapy may improve survival Researchers from Boston University College of Medicine have found that individuals with node negative T3 and T4 non-small lung cancer who all underwent chemotherapy before medical procedures had more than 3 x the survival rate than patients who all only underwent surgery.With the availability of the new long term data demonstrating that the advantages of Bronchial Thermoplasty persist for at least five years, I could confidently suggest BT as a therapeutic option to patients whose asthma is badly controlled with medications alone, said Dr. Wechsler. That is very important because minimizing the risk of recurrent asthma attacks and the associated need for oral steroid treatment in this patient population is a main aim in asthma therapy. Bronchial Thermoplasty represents a onetime, long term choice for attaining better asthma control in a select population of sufferers.